Papatui Acne Fighting Body

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It assists in maintaining clear skin by preventing the formation of new acne blemishes, acne pimples, blackheads, and whiteheads.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use. Prior to application, it is essential to clean the skin thoroughly to ensure optimal efficacy.

The product should be applied as a thin layer to the entire afflicted area. Initial dosing should begin with one application daily. Depending on the patient's response and as directed by a healthcare provider, the frequency may be gradually increased to two or three times daily.

It is important to monitor for signs of excessive drying of the skin. If bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day to mitigate these effects.

Contraindications

Use is contraindicated in patients with known hypersensitivity to any component of the formulation.

Application to the eyes is contraindicated; in case of contact, rinse thoroughly with water. Concurrent use with other topical acne medications may increase the risk of skin irritation and dryness; therefore, it is advised to use only one topical acne medication at a time if irritation occurs. The product should be applied exclusively to areas affected by acne.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. The contents are under pressure; puncturing or incinerating the container is strictly prohibited. Additionally, it should not be stored at temperatures exceeding 120°F.

Care should be taken to avoid contact with the eyes. In the event of contact, rinse thoroughly with water to remove the product. The use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. To minimize the risk of irritation, it is recommended that only one topical acne medication be used at a time.

Application should be limited to areas affected by acne. For individuals who are pregnant or breastfeeding, it is advisable to consult a healthcare professional prior to use.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is for external use only and is flammable; therefore, it should be kept away from fire or flame. The contents are under pressure, and users are advised not to puncture or incinerate the container. Additionally, it should not be stored at temperatures exceeding 120°F.

When using this product, it is crucial to avoid contact with the eyes. In the event of contact, the eyes should be rinsed with water to remove the product. Skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. To minimize the risk of irritation, it is recommended that only one topical acne medication be applied at a time and that the product be applied solely to areas affected by acne.

For pregnant or breastfeeding individuals, it is advised to consult a health professional prior to use. Furthermore, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Papatui Acne Fighting Body (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach, as ingestion may require immediate medical attention or contact with a Poison Control Center.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily based on clinical response and physician guidance. Should patients experience bothersome dryness or peeling, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

When using this product, it is important to emphasize that patients should avoid contact with the eyes. If the product does come into contact with the eyes, they should rinse thoroughly with water to remove it.

Additionally, healthcare providers should inform patients that the likelihood of skin irritation and dryness may increase if they use another topical acne medication concurrently. Therefore, if irritation occurs, patients should be advised to use only one topical acne medication at a time.

Finally, patients should be instructed to apply the product only to areas affected by acne to ensure safe and effective use.

Storage and Handling

The product is supplied in accordance with the National Drug Code (NDC) specifications. It should be stored at a controlled room temperature of 20-25°C (68-77°F), as defined by the United States Pharmacopeia (USP). It is essential to keep the product away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Papatui Acne Fighting Body, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)